1.10
price down icon0.89%   -0.0099
after-market After Hours: 1.16 0.06 +5.45%
loading
Processa Pharmaceuticals Inc stock is traded at $1.10, with a volume of 10,060. It is down -0.89% in the last 24 hours and down -7.56% over the past month. Processa Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on utilizing its "regulatory science" approach in the development of Next Generation Chemotherapy ("NGC") oncology drug products. The company's strategic prioritization is to advance its pipeline of NGC proprietary small molecule oncology drugs. The NGC products are new chemical entities, but the company work by changing the metabolism, distribution, and/or elimination of already FDA-approved cancer drugs or their active metabolites while maintaining the mechanism of how the drug kills cancer cells. The three NGC treatments in its pipeline are - NGC-Capecitabine (also referred to as NGC-Cap), PCS3117, also referred to as NGC-Gemcitabine (NGC-Gem), PCS11T, also referred to as NGC-Irinotecan (NGC-Iri).
See More
Previous Close:
$1.1099
Open:
$1.12
24h Volume:
10,060
Relative Volume:
0.15
Market Cap:
$3.74M
Revenue:
-
Net Income/Loss:
$-11.12M
P/E Ratio:
-0.7586
EPS:
-1.45
Net Cash Flow:
$-8.07M
1W Performance:
-18.52%
1M Performance:
-7.56%
6M Performance:
-49.31%
1Y Performance:
-99.21%
1-Day Range:
Value
$1.10
$1.172
1-Week Range:
Value
$1.05
$1.36
52-Week Range:
Value
$1.05
$348.00

Processa Pharmaceuticals Inc Stock (PCSA) Company Profile

Name
Name
Processa Pharmaceuticals Inc
Name
Phone
443-776-3133
Name
Address
7380 COCA COLA DRIVE, HANOVER
Name
Employee
13
Name
Twitter
Name
Next Earnings Date
2024-11-11
Name
Latest SEC Filings
Name
PCSA's Discussions on Twitter

Processa Pharmaceuticals Inc Stock (PCSA) Latest News

pulisher
02:19 AM

Gastroparesis Drugs Market to Grow by USD 1.42 Billion from 2024-2028, Driven by Rising Diabetes Rates and AI-Driven Market Trend InsightsTechnavio - The Malaysian Reserve

02:19 AM
pulisher
Nov 01, 2024

Processa Pharmaceuticals Reports Q3 2024 Financial Results - TipRanks

Nov 01, 2024
pulisher
Oct 31, 2024

Processa Pharmaceuticals stock hits 52-week low at $1.18 - Investing.com

Oct 31, 2024
pulisher
Oct 30, 2024

Processa Pharmaceuticals Reports Third Quarter Business Highlights and Financial Results - The Manila Times

Oct 30, 2024
pulisher
Oct 30, 2024

Processa Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Oct 30, 2024
pulisher
Oct 21, 2024

Colorectal Cancer Pipeline Overview 2024: FDA Approvals and Key Companies involved by DelveInsight | Novartis, Pharma Oncology, Purple Biotech Ltd, Plus Therapeutics, Processa Pharma - The Globe and Mail

Oct 21, 2024
pulisher
Oct 07, 2024

Gastroparesis Treatment Market Size, Demand, Trends, Analysis - openPR

Oct 07, 2024
pulisher
Oct 04, 2024

processa pharmaceuticals inc. Earnings dates - RTTNews

Oct 04, 2024
pulisher
Oct 03, 2024

Analytical Lens: Exploring Processa Pharmaceuticals Inc (PCSA)’s Financial Story Through Ratios - The Dwinnex

Oct 03, 2024
pulisher
Oct 03, 2024

Processa stock rallies 35% post-market on Phase 2 study update - MSN

Oct 03, 2024
pulisher
Oct 03, 2024

Processa Pharmaceuticals Announces First Patient Dosed in Phase 2 Clinical Trial of NGC-Cap in Metastatic Breast Cancer - ForexTV.com

Oct 03, 2024
pulisher
Oct 03, 2024

Constellation Brands, Levi Strauss And 3 Stocks To Watch Heading Into Thursday - Benzinga

Oct 03, 2024
pulisher
Sep 24, 2024

Pure Storage, Inc. (NYSE:PSTG) CRO Sells $450,709.65 in Stock - Defense World

Sep 24, 2024
pulisher
Sep 24, 2024

Peraso Inc’s latest rating changes from various analysts - Knox Daily

Sep 24, 2024
pulisher
Sep 24, 2024

Progress Software (PRGS) Q3 Earnings and Revenues Surpass Estimates - Yahoo Finance

Sep 24, 2024
pulisher
Sep 24, 2024

Progress Software Stock Jumps On Q3 Earnings: Revenue Beat, EPS Beat, Raised Guidance And More - TradingView

Sep 24, 2024
pulisher
Sep 24, 2024

Progress Software Corp (PRGS) Q3 2024 Earnings: EPS of $0.65 Bea - GuruFocus.com

Sep 24, 2024
pulisher
Sep 24, 2024

Perrigo shares downgraded amid restructuring efforts - Investing.com India

Sep 24, 2024
pulisher
Sep 24, 2024

Jefferies Financial Group Boosts Pacira BioSciences (NASDAQ:PCRX) Price Target to $18.00 - Defense World

Sep 24, 2024
pulisher
Sep 24, 2024

A Look at Pacira BioSciences Inc (PCRX) Shares in the Recent Past Indicates Growth - SETE News

Sep 24, 2024
pulisher
Sep 24, 2024

Check out these key findings about Privia Health Group Inc (PRVA) - SETE News

Sep 24, 2024
pulisher
Sep 24, 2024

Sagefield Capital LP Acquires 1,023,527 Shares of Permian Resources Co. (NASDAQ:PR) - Defense World

Sep 24, 2024
pulisher
Sep 24, 2024

Precigen Inc (PGEN)’s Ratio Roundup: Key Metrics for Trailing Twelve Months - The Dwinnex

Sep 24, 2024
pulisher
Sep 24, 2024

Monitoring Perrigo Company plc (PRGO) after recent insider movements - Knox Daily

Sep 24, 2024
pulisher
Sep 24, 2024

Pacira price target raised to $18 from $15 at Jefferies - TipRanks

Sep 24, 2024
pulisher
Sep 24, 2024

Get in on PureCycle Technologies Inc’s (PCT) buy-in window today! - SETE News

Sep 24, 2024
pulisher
Sep 24, 2024

72,064 Shares in Primoris Services Co. (NASDAQ:PRIM) Acquired by Appian Way Asset Management LP - MarketBeat

Sep 24, 2024
pulisher
Sep 24, 2024

Financial Snapshot: Analyzing PureCycle Technologies Inc (PCT)’s Key Ratio Metrics - The Dwinnex

Sep 24, 2024
pulisher
Sep 24, 2024

Primoris Services Co. (NASDAQ:PRIM) Shares Sold by Paradigm Capital Management Inc. NY - Defense World

Sep 24, 2024
pulisher
Sep 24, 2024

Dimensional Fund Advisors LP Has $108.58 Million Position in Perdoceo Education Co. (NASDAQ:PRDO) - Defense World

Sep 24, 2024
pulisher
Sep 24, 2024

Rs 5,890 Crore Order Book: Construction Company Secures Orders Worth Rs 554.92 Crore, FY25 Order Inflows Reach Rs 1,444.91 Crore – FIIs and DIIs Significantly Increase Stake - Dalal Street Investment Journal

Sep 24, 2024
pulisher
Sep 24, 2024

Should We Be Delighted With Poste Italiane S.p.A.'s (BIT:PST) ROE Of 18%? - Simply Wall St

Sep 24, 2024
pulisher
Sep 24, 2024

ProSiebenSat.1 Media (OTCMKTS:PBSFY) Shares Up 8.7% - Defense World

Sep 24, 2024
pulisher
Sep 23, 2024

Precigen Inc (PGEN) may enjoy gains as insiders got busy in the recent days - Knox Daily

Sep 23, 2024
pulisher
Sep 23, 2024

A look into Prothena Corporation plc (PRTA)’s deeper side - SETE News

Sep 23, 2024
pulisher
Sep 23, 2024

Understanding the Risks of Investing in Privia Health Group Inc (PRVA) - Knox Daily

Sep 23, 2024
pulisher
Sep 23, 2024

Is PureCycle Technologies Inc (PCT) a good investment opportunity? - US Post News

Sep 23, 2024
pulisher
Sep 23, 2024

Top Wall Street Forecasters Revamp Progress Software Price Expectations Ahead Of Q3 Earnings - Benzinga

Sep 23, 2024
pulisher
Sep 23, 2024

Morse Asset Management Inc Purchases 9,255 Shares of Primoris Services Co. (NASDAQ:PRIM) - MarketBeat

Sep 23, 2024
pulisher
Sep 23, 2024

Vanguard Personalized Indexing Management LLC Has $1.19 Million Holdings in POSCO Holdings Inc. (NYSE:PKX) - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

Victory Capital Management Inc. Boosts Stake in Privia Health Group, Inc. (NASDAQ:PRVA) - Defense World

Sep 23, 2024
pulisher
Sep 22, 2024

Pacer Advisors Inc. Purchases 518,048 Shares of Perdoceo Education Co. (NASDAQ:PRDO) - MarketBeat

Sep 22, 2024
pulisher
Sep 22, 2024

Federated Hermes Inc. Acquires Shares of 43,861 Prothena Co. plc (NASDAQ:PRTA) - MarketBeat

Sep 22, 2024
pulisher
Sep 22, 2024

Prothena Co. plc (NASDAQ:PRTA) Shares Acquired by Rhumbline Advisers - Defense World

Sep 22, 2024
pulisher
Sep 21, 2024

Insider Selling: Primoris Services Co. (NASDAQ:PRIM) Director Sells 25,000 Shares of Stock - MarketBeat

Sep 21, 2024
pulisher
Sep 21, 2024

Nkcfo LLC Acquires 20,525 Shares of Primoris Services Co. (NASDAQ:PRIM) - Defense World

Sep 21, 2024
pulisher
Sep 21, 2024

Primoris Services Co. (NASDAQ:PRIM) Director John P. Schauerman Sells 25,000 Shares - Defense World

Sep 21, 2024
pulisher
Sep 21, 2024

FDA Approval Propels ZVRA To 52-week High, ADMA, CPRX, TVTX Also Reach New Peaks - Nasdaq

Sep 21, 2024
pulisher
Sep 20, 2024

American Century Companies Inc. Sells 15,134 Shares of POSCO Holdings Inc. (NYSE:PKX) - Defense World

Sep 20, 2024
pulisher
Sep 20, 2024

Primoris Services director Schauerman sells $1.48m in stock By Investing.com - Investing.com Canada

Sep 20, 2024
pulisher
Sep 20, 2024

Inspire Investing LLC Buys 13,839 Shares of Permian Resources Co. (NASDAQ:PR) - Defense World

Sep 20, 2024

Processa Pharmaceuticals Inc Stock (PCSA) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Processa Pharmaceuticals Inc Stock (PCSA) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Young David
Pres. Research & Development
Feb 06 '24
Buy
2.53
20,000
50,504
58,387
Lin Patrick
Chief Business - Strategy Off
Jan 31 '24
Buy
2.37
2,500
5,925
25,978
Lin Patrick
Chief Business - Strategy Off
Feb 01 '24
Buy
2.40
1,500
3,600
27,478
Ng George K
Chief Executive Officer
Jan 30 '24
Buy
2.70
10,000
27,000
20,000
Yorke Justin W
Director
Jan 30 '24
Buy
2.69
8,000
21,544
31,232
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
Cap:     |  Volume (24h):